R and G PharmaStudies. (301333.SZ) Q1 2026 Earnings

28MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
0.36
0.38
0.4
0.42

Details

Expected EPS
N/A
Actual EPS
0.42487540448
Surprise EPS
0.42
Surprise Percent
+∞%

Description

R and G PharmaStudies. (301333.SZ) has reported earnings of 0.42487540448 per share for Q1 2026.

0 Comments

Share your thoughts